» Articles » PMID: 20375613

Signaling Pathways of the TREM-1- and TLR4-mediated Neutrophil Oxidative Burst

Overview
Journal J Innate Immun
Publisher Karger
Date 2010 Apr 9
PMID 20375613
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The triggering receptor expressed on myeloid cells 1 (TREM-1) is involved in the innate inflammatory response to microbial infections. Activation and expression of TREM-1 by polymorphonuclear neutrophils (PMN) occurs in concert with Toll-like receptors (TLR) such as TLR4 for bacterial lipopolysaccharide. However, it is currently unclear how this is mediated on a molecular level. Using pharmacological inhibitors and Western blot analysis we demonstrate that phosphatidyl inositide 3-kinase, phospholipase C and the mitogen-activated kinase p38MAPK are essential for the TREM-1- and TLR4-induced oxidative burst of human PMN. The activation of protein kinase B and extracellular signal-related kinase show characteristic phosphorylation patterns upon single or co-ligation indicating individual activation pathways of both receptors. Taken together, we provide new insights into the mechanisms how TREM-1 and TLR interact creating synergistic activation in PMN. These results shed a new light on our understanding of how the innate inflammatory responses are regulated and might contribute to the development of future concepts for the treatment of severe inflammatory conditions such as sepsis.

Citing Articles

The Interaction of HMGB1 with the Proinflammatory TREM-1 Receptor Generates Cytotoxic Lymphocytes Active against HLA-Negative Tumor Cells.

Yurkina D, Romanova E, Feoktistov A, Soshnikova N, Tvorogova A, Yashin D Int J Mol Sci. 2024; 25(1).

PMID: 38203798 PMC: 10779375. DOI: 10.3390/ijms25010627.


Soluble TREM-1 plasma levels are associated with acute kidney injury, acute atrial fibrillation and prolonged ICU stay after cardiac surgery- a proof-concept study.

Vandestienne M, Braik R, Lavillegrand J, Hariri G, Demailly Z, Ben Hamouda N Front Cardiovasc Med. 2023; 10:1098914.

PMID: 37522081 PMC: 10373879. DOI: 10.3389/fcvm.2023.1098914.


N-Terminal Peptide of PGLYRP1/Tag7 Is a Novel Ligand for TREM-1 Receptor.

Sharapova T, Ivanova O, Romanova E, Sashchenko L, Yashin D Int J Mol Sci. 2022; 23(10).

PMID: 35628562 PMC: 9144885. DOI: 10.3390/ijms23105752.


Transcriptomic Profiling Reveals a Role for TREM-1 Activation in Enterovirus D68 Infection-Induced Proinflammatory Responses.

Li J, Yang S, Liu S, Chen Y, Liu H, Su Y Front Immunol. 2021; 12:749618.

PMID: 34887856 PMC: 8650217. DOI: 10.3389/fimmu.2021.749618.


Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis.

Boufenzer A, Carrasco K, Jolly L, Brustolin B, Di-Pillo E, Derive M Cell Mol Immunol. 2021; 18(2):452-460.

PMID: 33420354 PMC: 8026640. DOI: 10.1038/s41423-020-00591-7.